Understanding Rheumatoid Arthritis: Causes, Symptoms, and Effective Management Through Physiotherapy
▫️Written by John Keller
✅ Reviewed by Dr. Jenny Hynes on December 23, 2024
Rheumatoid arthritis (RA) is a chronic autoimmune condition affecting millions worldwide. By understanding its causes, symptoms, and management strategies, individuals can improve their quality of life. This article delves into the essentials of RA, with a focus on physiotherapy's role in effective management.
What is Rheumatoid Arthritis?
Rheumatoid arthritis (RA) is more than just joint pain—it’s a systemic autoimmune condition that can significantly impact daily life. Understanding RA’s underlying mechanisms is key to managing its effects and maintaining an active lifestyle.
Rheumatoid arthritis is a chronic autoimmune disorder in which the immune system mistakenly attacks healthy joints and tissues. This process leads to inflammation, pain, and potential damage to other body systems, such as the eyes, lungs, and heart. Unlike osteoarthritis, which results from wear and tear, RA is driven by immune dysregulation, primarily affecting the synovium (the lining of joints).
RA often presents symmetrically, meaning if one hand or knee is affected, the other is likely involved. Understanding the distinction between RA and other types of arthritis is vital for proper diagnosis and treatment (Smolen et al., 2016).
By defining RA and its characteristics, we lay the foundation for understanding its far-reaching effects and why early intervention is so critical for effective management.
Types of Rheumatoid Arthritis
Rheumatoid arthritis is not a single disease but a condition with various subtypes, each presenting distinct diagnostic features and clinical implications. Understanding these types allows for more accurate diagnosis and personalized treatment approaches.
Seropositive Rheumatoid Arthritis: Seropositive RA is characterized by the presence of specific antibodies in the blood, namely rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. These antibodies signal an overactive immune system attacking healthy joint tissues. Patients with seropositive RA often experience more severe symptoms and are at higher risk for extra-articular manifestations such as rheumatoid nodules, lung disease, and cardiovascular complications. This subtype represents the majority of RA cases, and the presence of these antibodies helps confirm the diagnosis and predict disease progression (Aletaha et al., 2010).
Seronegative Rheumatoid Arthritis: In seronegative RA, blood tests do not detect RF or anti-CCP antibodies. Diagnosis relies on clinical symptoms, imaging, and exclusion of other conditions that mimic RA, such as psoriatic arthritis or osteoarthritis. Seronegative RA patients often exhibit joint pain, swelling, and stiffness similar to seropositive cases but may experience a less aggressive disease course. However, some seronegative patients later develop these antibodies, transitioning to seropositive RA (Smolen et al., 2016).
Juvenile Idiopathic Arthritis (JIA): Juvenile idiopathic arthritis is the most common type of arthritis in children, affecting those under the age of 16. It is an umbrella term for several subtypes, including systemic-onset JIA, oligoarticular JIA, and polyarticular JIA. Symptoms include joint swelling, pain, stiffness, and potential systemic features like fever and rash. Early diagnosis and intervention are crucial to prevent long-term joint damage and ensure normal growth and development. Unlike adult RA, JIA may remit in adolescence or adulthood, although some cases persist (Petty et al., 2016).
Other Subtypes:
Palindromic Rheumatism: This is an episodic form of RA where patients experience intermittent flares of joint inflammation that resolve completely between episodes. It can evolve into chronic RA over time.
Overlap Syndromes: These occur when RA coexists with other autoimmune conditions such as lupus (SLE) or scleroderma, complicating the clinical picture.
Felty’s Syndrome: A rare subtype associated with seropositive RA, characterized by an enlarged spleen and low white blood cell count, increasing the risk of infections.
Adult-Onset Still’s Disease (AOSD): A systemic inflammatory condition presenting with high fever, rash, and arthritis. Though distinct, it shares some clinical features with RA and requires careful differential diagnosis.
Recognizing the different types and subtypes of RA enables healthcare providers to tailor treatment plans and provide targeted interventions. This nuanced understanding ensures that patients receive the most appropriate and effective care for their specific presentation.
Causes of Rheumatoid Arthritis
Rheumatoid arthritis arises from a complex interplay of genetic, environmental, and hormonal factors. While the precise cause remains unknown, these contributing factors provide valuable insights into potential prevention and management strategies.
Genetic Factors: Genetic predisposition plays a critical role in the development of RA. Specific genes associated with the human leukocyte antigen (HLA) complex, particularly HLA-DR4 and HLA-DR1, are strongly linked to an increased risk of RA. These genes influence the immune system's ability to distinguish between self and non-self, leading to the inappropriate targeting of joint tissues. Studies suggest that individuals with these genetic markers are more likely to develop severe disease (Deane & Holers, 2019).
Environmental Triggers: Environmental exposures often act as catalysts in genetically susceptible individuals. Smoking is the most well-documented risk factor, doubling the likelihood of developing RA, especially in those with the HLA-DR4 gene. Chronic infections, such as those caused by Porphyromonas gingivalis (a bacterium associated with periodontal disease), have been implicated in triggering autoimmunity. Additionally, exposure to silica dust and other occupational hazards may increase systemic inflammation and autoimmune activation. Psychological stress is another potential contributor, as it exacerbates immune dysregulation and may precipitate RA onset (Chang et al., 2014).
Hormonal Influences: The predominance of RA in women, with a female-to-male ratio of approximately 3:1, underscores the role of hormones in disease development. Estrogen and progesterone appear to modulate immune responses, with fluctuations in these hormones during pregnancy, postpartum, and menopause influencing disease activity. For instance, RA symptoms often improve during pregnancy but flare after delivery. These hormonal shifts likely affect the balance between pro-inflammatory and anti-inflammatory pathways, contributing to disease pathogenesis (Cutolo et al., 2002).
Interaction of Factors: RA is rarely attributable to a single factor. Instead, it emerges from the interaction of genetic predisposition, environmental exposures, and hormonal influences. For example, a person with HLA-DR4 who smokes may experience heightened production of autoantibodies such as anti-cyclic citrullinated peptide (anti-CCP). This immune activation is further exacerbated by infections or hormonal imbalances, creating a "perfect storm" for RA onset. Understanding these interactions highlights the importance of a multifaceted approach to prevention and treatment (Smolen et al., 2016).
The causes of RA are complex and multifactorial, involving the interplay of genetics, environment, and hormones. By addressing modifiable risk factors and enhancing our understanding of these interactions, we can better manage and potentially mitigate the impact of RA.
Signs and symptoms of Rheumatoid Arthritis
Rheumatoid arthritis manifests in various ways, affecting not only the joints but also other body systems. Recognizing these signs and symptoms early is crucial for timely diagnosis and effective management.
Joint Pain, Swelling, and Stiffness: Joint pain is a hallmark symptom of RA, typically accompanied by swelling and stiffness. The small joints of the hands, wrists, and feet are often the first to be affected. Over time, larger joints such as the knees, shoulders, and hips may also become involved. Pain is usually described as a persistent, dull ache, exacerbated by activity and often worse in the morning or after periods of inactivity. Morning stiffness lasting more than 30 minutes is a distinguishing feature of RA, setting it apart from other forms of arthritis (McInnes & Schett, 2017).
Fatigue: Chronic fatigue is a common and debilitating symptom of RA. It is driven by systemic inflammation, anemia of chronic disease, and disrupted sleep due to joint pain. Fatigue significantly impacts quality of life, affecting physical function, mental health, and social participation. Studies have shown that fatigue in RA patients correlates strongly with disease activity and inflammation levels (Matcham et al., 2016).
Fever: Low-grade fever is a systemic symptom that may accompany RA, particularly during active disease flares. This fever reflects the heightened immune response and systemic inflammation associated with RA. Persistent fever warrants further evaluation to rule out infections or other complications (Smolen et al., 2016).
Weight Loss: Unintentional weight loss can occur in RA due to systemic inflammation and increased metabolic demand. Cytokines such as tumor necrosis factor-alpha (TNF-α) contribute to muscle wasting and reduced appetite, leading to cachexia in severe cases. Weight loss may also reflect extra-articular complications or comorbid conditions (Walsmith & Roubenoff, 2002).
Symmetrical Pattern of Symptoms: A defining characteristic of RA is its symmetrical involvement of joints. For example, if the small joints of the left hand are affected, the corresponding joints on the right hand are often similarly involved. This symmetry helps distinguish RA from other types of arthritis, such as osteoarthritis, which typically affects joints asymmetrically (McInnes & Schett, 2017).
Extra-Articular Manifestations: RA is a systemic disease that can affect multiple organ systems:
Eyes: Conditions such as scleritis and keratoconjunctivitis sicca (dry eye syndrome) are common.
Lungs: Interstitial lung disease, pleuritis, and pulmonary nodules are potential complications.
Heart: RA increases the risk of cardiovascular disease, including pericarditis and atherosclerosis.
Skin: Rheumatoid nodules develop in about 20-30% of seropositive RA patients, typically over pressure points like the elbows.
Nervous System: Peripheral neuropathy and carpal tunnel syndrome may occur due to nerve compression and systemic inflammation (Young et al., 2007).
Recognizing the wide range of symptoms and manifestations of RA is essential for early diagnosis and intervention. Addressing these symptoms holistically can significantly improve outcomes and quality of life for individuals with RA.
Diagnosis of Rheumatoid Arthritis
Accurate diagnosis of rheumatoid arthritis is essential for initiating timely treatment and preventing joint damage. Diagnosis involves a combination of physical examinations, laboratory tests, imaging, and adherence to standardized criteria.
Physical Examination: During a physical exam, doctors assess joint swelling, tenderness, warmth, and range of motion. They often look for symmetrical joint involvement and inflammation, particularly in the small joints of the hands, wrists, and feet. Signs such as deformities, rheumatoid nodules, or reduced grip strength can indicate advanced disease. Morning stiffness lasting more than 30 minutes and systemic symptoms like fatigue and fever are also key clinical features (Smolen et al., 2016).
Blood Tests: Laboratory tests are crucial for confirming an RA diagnosis and evaluating disease activity:
Rheumatoid Factor (RF): RF is an autoantibody present in approximately 70-80% of RA patients. While elevated RF levels suggest RA, it is not entirely specific and may appear in other autoimmune or infectious conditions.
Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibodies: Anti-CCP is a highly specific marker for RA, often detected in early disease stages. High anti-CCP levels are associated with more severe joint damage and a greater likelihood of extra-articular manifestations.
Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP): Both ESR and CRP are markers of systemic inflammation. Elevated levels often correlate with disease flares and provide a baseline for monitoring treatment response (Aletaha et al., 2010).
Imaging Tests: Imaging is critical for detecting early joint changes and assessing the extent of damage:
X-Rays: Useful for identifying joint erosions, subluxations, and narrowing of joint spaces in later stages of RA.
Magnetic Resonance Imaging (MRI): MRI provides detailed images of soft tissues, enabling early detection of synovitis, bone marrow edema, and subtle erosions. It is particularly valuable for identifying changes before permanent joint damage occurs.
Ultrasound: A non-invasive tool that detects synovial thickening, joint effusions, and early erosions. Power Doppler ultrasound can visualize active inflammation, aiding in disease activity monitoring (McQueen et al., 1999).
Diagnostic Criteria: The American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) developed the 2010 classification criteria to improve diagnostic accuracy. These criteria assign points based on:
Joint Involvement: Larger points are given for small joint involvement, with a maximum score for more than ten joints.
Serological Markers: Presence of RF and/or anti-CCP.
Acute-Phase Reactants: Elevated ESR and/or CRP.
Symptom Duration: Symptoms persisting for six weeks or longer. A total score of 6 or more confirms an RA diagnosis. This standardized framework ensures consistency in diagnosing RA across clinical settings (Aletaha et al., 2010).
The diagnosis of rheumatoid arthritis relies on a comprehensive evaluation combining clinical symptoms, serological findings, and imaging results. Early and accurate diagnosis is critical for initiating effective treatment, minimizing joint damage, and improving long-term outcomes.
Prevention of Rheumatoid Arthritis
While there is no definitive way to prevent rheumatoid arthritis (RA), certain lifestyle modifications and proactive health measures can reduce the risk of developing RA or mitigate its severity. Early intervention is particularly important in preventing irreversible joint damage.
Lifestyle Factors That May Reduce Risk:
Non-Smoking: Smoking is the most significant modifiable risk factor for RA, particularly in individuals with a genetic predisposition. Studies show that smoking increases the production of anti-CCP antibodies, which are linked to aggressive RA (Chang et al., 2014). Avoiding tobacco products can lower the likelihood of developing RA and improve outcomes for those already diagnosed.
Maintaining a Healthy Weight: Obesity is associated with increased systemic inflammation, which can exacerbate autoimmune activity. Maintaining a healthy weight through a balanced diet and regular exercise helps reduce the inflammatory burden and may lower RA risk.
Good Oral Hygiene: Emerging evidence links periodontal disease to an increased risk of RA. Bacteria such as Porphyromonas gingivalis can promote systemic inflammation and the production of autoantibodies. Practicing good oral hygiene and seeking timely dental care can reduce this risk (Potempa et al., 2017).
Early Intervention: Early diagnosis and treatment are critical in preventing joint damage and long-term disability. Identifying early symptoms such as joint stiffness, swelling, and fatigue and consulting a healthcare provider can lead to prompt initiation of disease-modifying therapies. Studies have shown that initiating DMARDs (disease-modifying antirheumatic drugs) within the first six months of symptom onset significantly improves long-term outcomes (Smolen et al., 2016).
Genetic Counseling: For individuals with a family history of RA, genetic counseling can provide insights into their risk level. While genetic predisposition cannot be altered, counseling may encourage proactive lifestyle changes and regular monitoring for early signs of the disease. This approach can lead to earlier diagnosis and treatment, mitigating the disease’s impact.
Preventing rheumatoid arthritis involves addressing modifiable risk factors, such as smoking and obesity, while emphasizing early detection and intervention. Although RA cannot be entirely avoided, these proactive measures can significantly reduce its severity and improve quality of life.
Treatment options for Rheumatoid Arthritis
Effective management of rheumatoid arthritis involves a combination of pharmacological treatments, lifestyle adjustments, and, in some cases, surgical interventions. Each treatment modality targets different aspects of the disease to reduce symptoms, prevent joint damage, and enhance quality of life.
Medications:
Disease-Modifying Antirheumatic Drugs (DMARDs): DMARDs are the cornerstone of RA treatment as they slow disease progression and reduce joint damage. Methotrexate, the most commonly prescribed DMARD, works by suppressing the immune system and reducing inflammation. Other DMARDs, such as sulfasalazine and leflunomide, offer alternative options for patients who cannot tolerate methotrexate. Early initiation of DMARDs is crucial for achieving disease remission (Singh et al., 2016).
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs, such as ibuprofen and naproxen, are effective in managing pain and inflammation but do not alter disease progression. They are often used in conjunction with DMARDs to provide symptomatic relief. Long-term use of NSAIDs requires monitoring for gastrointestinal and cardiovascular side effects (Smolen et al., 2016).
Corticosteroids: Corticosteroids, such as prednisone, provide rapid relief from inflammation and joint pain, especially during disease flares. They are often used as a short-term solution to control acute symptoms while waiting for DMARDs to take effect. Prolonged use of corticosteroids can lead to adverse effects such as osteoporosis, weight gain, and increased infection risk, necessitating cautious management (Cutolo et al., 2002).
Biologic Agents: Biologics are advanced, targeted therapies designed to inhibit specific components of the immune system. Tumor necrosis factor (TNF) inhibitors, such as adalimumab and etanercept, block inflammatory cytokines, reducing joint damage and systemic inflammation. Other biologics, like interleukin-6 inhibitors (e.g., tocilizumab) and B-cell depleting agents (e.g., rituximab), offer options for patients unresponsive to traditional DMARDs. Biologics have revolutionized RA treatment but require careful monitoring for infections and other complications (Smolen et al., 2016).
Surgical Interventions: Surgery is considered when joint damage becomes severe and limits function despite optimal medical management. Procedures include:
Synovectomy: Removal of inflamed synovial tissue to reduce pain and swelling.
Joint Replacement: Total joint arthroplasty, particularly in the hips or knees, to restore mobility and alleviate pain in severely damaged joints.
Tendon Repair: Addressing tendon rupture or deformities caused by chronic inflammation. Surgery is generally reserved for advanced cases and is often followed by physiotherapy to optimize recovery and restore function (van der Heijde et al., 2018).
Lifestyle Changes:
Diet: An anti-inflammatory diet rich in fruits, vegetables, whole grains, and omega-3 fatty acids can help reduce systemic inflammation. Foods like salmon, walnuts, and flaxseeds are particularly beneficial. Conversely, processed foods and those high in sugar and saturated fats may exacerbate inflammation.
Exercise: Regular, low-impact physical activity such as swimming, yoga, or cycling helps maintain joint flexibility, strengthen muscles, and improve overall cardiovascular health. Tailored exercise programs supervised by a physiotherapist ensure safety and effectiveness.
Stress Management: Chronic stress can worsen RA symptoms by increasing inflammation. Mindfulness techniques, cognitive-behavioral therapy, and relaxation exercises can improve mental health and reduce disease activity (Polinski et al., 2020).
Smoking Cessation: Quitting smoking is critical for RA patients as smoking exacerbates disease activity and reduces the effectiveness of treatments, particularly biologics.
The treatment of rheumatoid arthritis requires a comprehensive approach that combines medications, lifestyle changes, and, when necessary, surgical interventions. Early and proactive management can significantly improve outcomes and enhance the quality of life for individuals living with RA.
Physiotherapy for Rheumatoid Arthritis
At Keilor Road Physiotherapy, we specialize in providing tailored physiotherapy programs to help individuals with rheumatoid arthritis (RA) manage their symptoms, maintain joint function, and improve overall quality of life. Physiotherapy plays an essential role in addressing the challenges of RA by offering evidence-based treatments that target pain relief, mobility, and long-term joint health.
How Physiotherapy Can Help: Physiotherapy focuses on reducing inflammation, maintaining joint mobility, and preventing deformities associated with RA. By employing a combination of manual therapy, exercise regimens, and patient education, we aim to improve joint functionality and enhance daily activities. Regular physiotherapy sessions can also help alleviate muscle stiffness, improve circulation, and promote overall well-being (Cooney et al., 2011).
Specific Techniques and Exercises:
Range-of-Motion Exercises: Gentle range-of-motion exercises are designed to maintain flexibility and reduce joint stiffness. These exercises help prevent joint contractures and ensure optimal movement without exacerbating inflammation.
Strengthening Exercises: Strengthening exercises focus on building the muscles around affected joints to provide additional support. At Keilor Road Physiotherapy, we customize strength training routines using resistance bands and body weight exercises, tailored to each patient’s abilities (Cooney et al., 2011).
Aerobic Exercises: Low-impact aerobic exercises, such as walking, cycling, or swimming, are recommended to enhance cardiovascular health and reduce fatigue. Regular aerobic activity has been shown to decrease inflammation markers and improve mood (Polinski et al., 2020).
Joint Protection Techniques: We educate patients on joint protection strategies, such as proper body mechanics and energy conservation techniques, to minimize stress on inflamed joints. Assistive devices, like splints or braces, may also be recommended to support joint alignment during activities.
Benefits of Physiotherapy in Managing RA: Patients who engage in physiotherapy experience:
Improved joint mobility and flexibility.
Reduced pain and stiffness.
Enhanced muscular strength and endurance.
Greater ability to perform daily tasks independently.
Increased overall quality of life and emotional well-being.
How Physiotherapy Complements Other Treatments: Physiotherapy works synergistically with medical treatments, including medications like DMARDs and biologics, to address RA comprehensively. By combining physiotherapy with pharmacological and lifestyle interventions, patients achieve better symptom control and reduced disease progression (Singh et al., 2016).
Case Study: Sarah, a 42-year-old teacher, was diagnosed with seropositive RA two years ago. She experienced severe morning stiffness and difficulty managing her classroom duties due to hand pain and fatigue. After starting a tailored physiotherapy program at Keilor Road Physiotherapy, Sarah incorporated range-of-motion and strengthening exercises into her routine. Within three months, she reported improved grip strength, reduced stiffness, and enhanced energy levels. With ongoing physiotherapy and her prescribed medication regimen, Sarah successfully returned to her full teaching schedule.
At Keilor Road Physiotherapy, we are committed to helping individuals with RA lead active and fulfilling lives. Our personalized approach ensures that every patient receives the care and support needed to manage their condition effectively. Whether it’s relieving pain, improving mobility, or enhancing quality of life, physiotherapy is a vital component of RA management.
Living with Rheumatoid Arthritis
Living with rheumatoid arthritis (RA) involves not just managing physical symptoms but also addressing emotional, social, and occupational challenges. At Keilor Road Physiotherapy, we provide comprehensive support to help patients adapt and thrive despite the complexities of RA.
Coping Strategies: The psychological impact of living with RA can be profound. Chronic pain, fatigue, and physical limitations often lead to stress, anxiety, or depression. We encourage patients to adopt coping mechanisms such as mindfulness meditation, cognitive-behavioral therapy, and relaxation techniques. Engaging in hobbies, maintaining a strong support network, and seeking counseling when needed can significantly improve mental health outcomes (Polinski et al., 2020).
Support Groups and Resources: Connecting with others who understand the challenges of RA can be empowering. We direct our patients to local support groups and online forums, such as those offered by Arthritis Australia or the Rheumatoid Arthritis Support Network. These platforms provide emotional support, practical tips, and opportunities to share experiences.
Assistive Devices: Assistive tools can make daily tasks easier and reduce strain on affected joints. Devices like ergonomic utensils, jar openers, and grab bars enhance independence and safety. At Keilor Road Physiotherapy, we assess each patient’s needs and recommend appropriate aids to improve functionality and comfort.
Work Accommodations: RA can pose challenges in the workplace, but with appropriate adjustments, many individuals continue to work productively. Flexible scheduling, ergonomic workstations, and modified duties can alleviate strain and accommodate physical limitations. We collaborate with occupational therapists to ensure patients receive necessary workplace modifications.
Living with RA requires a multifaceted approach that goes beyond medical treatment. At Keilor Road Physiotherapy, we empower patients with the tools, strategies, and support they need to manage their condition effectively and maintain a fulfilling lifestyle.
Conclusion
Rheumatoid arthritis (RA) is a complex autoimmune condition that impacts not only physical health but also emotional and social well-being. Early diagnosis, a comprehensive treatment approach, and ongoing management are essential to minimizing its effects. Key strategies include a combination of medical treatment, physiotherapy, and lifestyle changes to improve joint function, reduce pain, and enhance quality of life.
Navigating RA can be challenging, but you don’t have to do it alone. Collaborating with healthcare professionals, including physiotherapists at Keilor Road Physiotherapy, ensures you receive the best care tailored to your unique needs. From symptom management to maintaining daily independence, professional guidance is invaluable.
While living with RA presents challenges, advancements in treatment and supportive care mean that individuals can lead active, fulfilling lives. With the right strategies, support, and determination, managing RA effectively is within reach. At Keilor Road Physiotherapy, we are here to guide you every step of the way on your journey to improved health and well-being.
References:
Aletaha, D., Neogi, T., Silman, A. J., et al. (2010). Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism, 62(9), 2569-2581.
Chang, K., Yang, S. M., Kim, S. H., et al. (2014). Smoking and rheumatoid arthritis. International Journal of Molecular Sciences, 15(12), 22279-22305.
Cooney, J. K., Law, R. J., Matschke, V., et al. (2011). Benefits of exercise in rheumatoid arthritis. Journal of Aging Research, 2011, 681640.
Cutolo, M., Seriolo, B., Villaggio, B., Pizzorni, C., Craviotto, C., & Sulli, A. (2002). Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Annals of the New York Academy of Sciences, 966, 131–142. https://doi.org/10.1111/j.1749-6632.2002.tb04210.x
Deane, K. D., & Holers, V. M. (2019). The Natural History of Rheumatoid Arthritis. Clinical therapeutics, 41(7), 1256–1269. https://doi.org/10.1016/j.clinthera.2019.04.028
Polinski, K. J., Bemis, E. A., Feser, M., Seifert, J., Demoruelle, M. K., Striebich, C. C., Brake, S., O'Dell, J. R., Mikuls, T. R., Weisman, M. H., Gregersen, P. K., Keating, R. M., Buckner, J., Nicassio, P., Holers, V. M., Deane, K. D., & Norris, J. M. (2020). Perceived Stress and Inflammatory Arthritis: A Prospective Investigation in the Studies of the Etiologies of Rheumatoid Arthritis Cohort. Arthritis care & research, 72(12), 1766–1771. https://doi.org/10.1002/acr.24085
McInnes, I. B., & Schett, G. (2017). Pathogenetic insights from the treatment of rheumatoid arthritis. The Lancet, 389(10086), 2328-2337.
McQueen, F. M., Stewart, N., Crabbe, J., Robinson, E., Yeoman, S., Tan, P. L., & McLean, L. (1999). Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Annals of the rheumatic diseases, 58(3), 156–163. https://doi.org/10.1136/ard.58.3.156
Matcham, F., Rayner, L., Steer, S., et al. (2016). The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology, 55(4), 629-642.
Potempa, J., Mydel, P., & Koziel, J. (2017). The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nature Reviews Rheumatology, 13(10), 606-620.
Singh, J. A., Saag, K. G., Bridges, S. L., et al. (2016). 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care & Research, 68(1), 1-25.
Smolen, J. S., Aletaha, D., McInnes, I. B. (2016). Rheumatoid arthritis. The Lancet, 388(10055), 2023-2038.
van der Heijde, D., Daikh, D. I., Betteridge, N., Burmester, G. R., Hassett, A. L., Matteson, E. L., van Vollenhoven, R., & Lakhanpal, S. (2018). Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Annals of the rheumatic diseases, 77(6), 829–832. https://doi.org/10.1136/annrheumdis-2017-212565
Walsmith, J., & Roubenoff, R. (2002). Cachexia in rheumatoid arthritis. International Journal of Cardiology, 85(1), 89-99.
Young, A., Koduri, G., Batley, M., Kulinskaya, E., Gough, A., Norton, S., Dixey, J., & Early Rheumatoid Arthritis Study (ERAS) group (2007). Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford, England), 46(2), 350–357. https://doi.org/10.1093/rheumatology/kel253
Article by
John Keller
Clinical Director | Sports & Musculoskeletal Physiotherapist
John graduated as a Physiotherapist from the Auckland University of Technology with the John Morris memorial prize for outstanding clinical practise in 2003. John has since completed Post Graduate Diplomas in both Sports Medicine and Musculoskeletal Physiotherapy with distinction, also collecting the Searle Shield for excellence in Musculoskeletal Physiotherapy.
Reviewed by
Dr. Jenny Hynes FACP
Clinical Director | Specialist Musculoskeletal Physiotherapist
Jenny sat extensive examinations to be inducted as a fellow into the Australian College of Physiotherapy in 2009 and gain the title of Specialist Musculoskeletal Physiotherapist, one of only a few physiotherapists in the state to have done so.
“Whatever it is, the way you tell your story online can make all the difference.”